These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 11960641)
21. Fractalkine gene therapy for neuroblastoma is more effective in combination with targeted IL-2. Zeng Y; Jiang J; Huebener N; Wenkel J; Gaedicke G; Xiang R; Lode HN Cancer Lett; 2005 Oct; 228(1-2):187-93. PubMed ID: 15953676 [TBL] [Abstract][Full Text] [Related]
22. Role of Fractalkine-CX3CR1 Axis in Acute Rejection of Mouse Heart Allografts Subjected to Ischemia Reperfusion Injury. Kanzawa T; Tokita D; Saiga K; Yamakawa T; Ishigooka H; Fukuda H; Katsumata H; Miyairi S; Ishii R; Hirai T; Imai T; Okumi M; Tanabe K Transpl Int; 2022; 35():10157. PubMed ID: 35185378 [TBL] [Abstract][Full Text] [Related]
23. Fractalkine cleavage from neuronal membranes represents an acute event in the inflammatory response to excitotoxic brain damage. Chapman GA; Moores K; Harrison D; Campbell CA; Stewart BR; Strijbos PJ J Neurosci; 2000 Aug; 20(15):RC87. PubMed ID: 10899174 [TBL] [Abstract][Full Text] [Related]
24. Antitumor immune response by CX3CL1 fractalkine gene transfer depends on both NK and T cells. Xin H; Kikuchi T; Andarini S; Ohkouchi S; Suzuki T; Nukiwa T; Huqun ; Hagiwara K; Honjo T; Saijo Y Eur J Immunol; 2005 May; 35(5):1371-80. PubMed ID: 15789339 [TBL] [Abstract][Full Text] [Related]
25. Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, during acute and chronic inflammation in the rodent CNS. Hughes PM; Botham MS; Frentzel S; Mir A; Perry VH Glia; 2002 Mar; 37(4):314-27. PubMed ID: 11870871 [TBL] [Abstract][Full Text] [Related]
26. Targeted deletion of CX(3)CR1 reveals a role for fractalkine in cardiac allograft rejection. Haskell CA; Hancock WW; Salant DJ; Gao W; Csizmadia V; Peters W; Faia K; Fituri O; Rottman JB; Charo IF J Clin Invest; 2001 Sep; 108(5):679-88. PubMed ID: 11544273 [TBL] [Abstract][Full Text] [Related]
27. [Expression of fractalkine and its receptor in acute cardiac allografts rejection]. Gu X; Tang XD; Gu SY; Yang SQ; Zhou PJ; Tan JM Zhonghua Wai Ke Za Zhi; 2003 Feb; 41(2):139-42. PubMed ID: 12783679 [TBL] [Abstract][Full Text] [Related]
29. Fractalkine reduces N-methyl-d-aspartate-induced calcium flux and apoptosis in human neurons through extracellular signal-regulated kinase activation. Deiva K; Geeraerts T; Salim H; Leclerc P; Héry C; Hugel B; Freyssinet JM; Tardieu M Eur J Neurosci; 2004 Dec; 20(12):3222-32. PubMed ID: 15610155 [TBL] [Abstract][Full Text] [Related]
30. Antagonist of fractalkine (CX3CL1) delays the initiation and ameliorates the progression of lupus nephritis in MRL/lpr mice. Inoue A; Hasegawa H; Kohno M; Ito MR; Terada M; Imai T; Yoshie O; Nose M; Fujita S Arthritis Rheum; 2005 May; 52(5):1522-33. PubMed ID: 15880599 [TBL] [Abstract][Full Text] [Related]
31. Enhanced recruitment of CX3CR1+ T cells by mucosal endothelial cell-derived fractalkine in inflammatory bowel disease. Sans M; Danese S; de la Motte C; de Souza HS; Rivera-Reyes BM; West GA; Phillips M; Katz JA; Fiocchi C Gastroenterology; 2007 Jan; 132(1):139-53. PubMed ID: 17241867 [TBL] [Abstract][Full Text] [Related]
32. Fractalkine is a novel chemoattractant for rheumatoid arthritis fibroblast-like synoviocyte signaling through MAP kinases and Akt. Volin MV; Huynh N; Klosowska K; Chong KK; Woods JM Arthritis Rheum; 2007 Aug; 56(8):2512-22. PubMed ID: 17665439 [TBL] [Abstract][Full Text] [Related]
33. Role of CX3C-chemokine CX3C-L/fractalkine expression in a model of slowly progressive renal failure. Koziolek MJ; Müller GA; Zapf A; Patschan D; Schmid H; Cohen CD; Koschnick S; Vasko R; Bramlage C; Strutz F Nephrol Dial Transplant; 2010 Mar; 25(3):684-98. PubMed ID: 19934081 [TBL] [Abstract][Full Text] [Related]
34. Evolution of brain infarction after transient focal cerebral ischemia in mice. Hata R; Maeda K; Hermann D; Mies G; Hossmann KA J Cereb Blood Flow Metab; 2000 Jun; 20(6):937-46. PubMed ID: 10894177 [TBL] [Abstract][Full Text] [Related]
35. T cell costimulation by fractalkine-expressing synoviocytes in rheumatoid arthritis. Sawai H; Park YW; Roberson J; Imai T; Goronzy JJ; Weyand CM Arthritis Rheum; 2005 May; 52(5):1392-401. PubMed ID: 15880821 [TBL] [Abstract][Full Text] [Related]
36. Dual role of Fcgamma receptor in transient focal cerebral ischemia in mice. Komine-Kobayashi M; Chou N; Mochizuki H; Nakao A; Mizuno Y; Urabe T Stroke; 2004 Apr; 35(4):958-63. PubMed ID: 14988576 [TBL] [Abstract][Full Text] [Related]
37. Inhibition of cytokine-induced fractalkine production by bacterial invasion of human-dermal fibroblasts. Fahy OL; Coates NJ; McColl SR Lab Invest; 2003 May; 83(5):721-30. PubMed ID: 12746481 [TBL] [Abstract][Full Text] [Related]
38. Increased serum levels of soluble fractalkine (CX3CL1) correlate with disease activity in rheumatoid vasculitis. Matsunawa M; Isozaki T; Odai T; Yajima N; Takeuchi HT; Negishi M; Ide H; Adachi M; Kasama T Arthritis Rheum; 2006 Nov; 54(11):3408-16. PubMed ID: 17075825 [TBL] [Abstract][Full Text] [Related]
39. Fractalkine (FRK) levels in amniotic fluid and its production during pregnancy. Shimoya K; Zhang Q; Tenma K; Ota Y; Hashimoto K; Shizusawa Y; Kimura T; Koyama M; Murata Y Mol Hum Reprod; 2003 Feb; 9(2):97-101. PubMed ID: 12569179 [TBL] [Abstract][Full Text] [Related]